Mutations in LPIN1 Cause Recurrent Acute Myoglobinuria in Childhood

Dubowitz, 1995, Metabolic myopathies, 177 Tein, 1990, Recurrent childhood myoglobinuria, Adv. Pediatr., 37, 77 Tonin, 1990, Metabolic causes of myoglobinuria, Ann. Neurol., 27, 181, 10.1002/ana.410270214 Edvardson, 2007, Deleterious mutation in the mitochondrial arginyl-tRNA synthetase gene is associated with ponto-cerebellar hypoplasia, Am. J. Hum. Genet., 81, 857, 10.1086/521227 Langner, 1989, The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities, J. Biol. Chem., 264, 7994, 10.1016/S0021-9258(18)83141-6 Péterfy, 2001, Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin, Nat. Genet., 27, 121, 10.1038/83685 Phan, 2005, Lipin, a lipodystrophy and obesity gene, Cell Metab., 1, 73, 10.1016/j.cmet.2004.12.002 Donkor, 2007, Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns, J. Biol. Chem., 282, 3450, 10.1074/jbc.M610745200 Han, 2006, The Saccharomyces cerevisiae Lipin homolog is a Mg2+-dependent phosphatidate phosphatase enzyme, J. Biol. Chem., 281, 9210, 10.1074/jbc.M600425200 Han, 2007, The cellular functions of the yeast lipin homolog PAH1p are dependent on its phosphatidate phosphatase activity, J. Biol. Chem., 282, 37026, 10.1074/jbc.M705777200 Stein, 1994, The single translation product of the FUM1 gene (fumarase) is processed in mitochondria before being distributed between the cytosol and mitochondria in Saccharomyces cerevisiae, Mol. Cell. Biol., 14, 4770, 10.1128/MCB.14.7.4770 Ucar, 2000, HMG-CoA reductase inhibitors and myotoxicity, Drug Saf., 22, 441, 10.2165/00002018-200022060-00003 Shek, 2001, Statin-fibrate combination therapy, Ann. Pharmacother., 35, 908, 10.1345/aph.10315 Link, 2008, SLCO1B1 variants and Statin-induced myopathy—A genomewide study, N. Engl. J. Med., 359, 789, 10.1056/NEJMoa0801936 Vladutiu, 2006, Genetic risk factors associated with lipid-lowering drug-induced myopathies, Muscle Nerve, 34, 153, 10.1002/mus.20567 Langner, 1991, Characterization of the peripheral neuropathy in neonatal and adult mice that are homozygous for the fatty liver dystrophy (fld) mutation, J. Biol. Chem., 266, 11955, 10.1016/S0021-9258(18)99050-2 Valianpour, 2005, Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis, J. Lipid Res., 46, 1182, 10.1194/jlr.M500056-JLR200 Lands, 1958, Metabolism of glycerolipides: A comparison of lecithin and triglyceride synthesis, J. Biol. Chem., 231, 883, 10.1016/S0021-9258(18)70453-5 Nakagawa, 1989, The metabolism of glycerophospholipid and its regulation in monocytes and macrophages, Prog. Lipid Res., 28, 205, 10.1016/0163-7827(89)90013-1 Farooqui, 2000, Glycerophospholipids in brain: Their metabolism, incorporation into membranes, functions, and involvement in neurological disorders, Chem. Phys. Lipids, 106, 1, 10.1016/S0009-3084(00)00128-6